GEODE CAPITAL MANAGEMENT, LLC
Position in DMII — Drugs Made In America Acquisition II Corp.
CIK 1214717
BOSTON, MA
Position in DMII
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$395,300
+$129,971 QoQ
Shares Held
39,649
+47.9% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DMII Over Time
Shares Held
Position Value (USD)
Position in Shell Companies
Financial Services · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $44,836,959 across 67 Shell Companies names. DMII ranks #17 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XXI |
Twenty One Capital, Inc.
|
4,051,834 | $25,931,737 | |
| 2 | VLOS |
Velos Acquisition I Corp.
|
90,428 | $971,196 | |
| 3 | KFII |
K&F Growth Acquisition Corp. II
|
83,571 | $871,645 | |
| 4 | NMP |
NMP Acquisition Corp.
|
80,955 | $822,502 | |
| 5 | SOCA |
Solarius Capital Acquisition Corp.
|
76,097 | $773,906 | |
| 6 | CEPF |
Cantor Equity Partners IV, Inc.
|
74,080 | $754,875 | |
| 7 | IPCX |
Inflection Point Acquisition Corp. III
|
65,591 | $670,012 | |
| 8 | DMAA |
Drugs Made In America Acquisition Corp.
|
62,273 | $652,621 |
All Filings in DMII
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $395,300 | 39,649 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $265,329 | 26,801 | Shares | Defined | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||